David Kiang, M.D.

Selected Publications

Li GY, Lin HH, Tu, ZJ, Kiang DT.  Gap junction Cx26 gene modulation by phorbol esters in benign and malignant human mammary cells.  Gene 1998; 209:  139-147.

You S, Tu ZJ, Kiang DT.  Direct modulation of tumor suppressor Connexin 26 gene by human chorionic gonadotropin in rat mammary glands.  Cancer Res 1998; 58:  1498-1502.

Tu ZJ, Kiang DT.  Mapping and Characterization of the Basal Promoter of the Human Connexin 26 Gene.  Biochim Biophys Acta 1998; 1443:  169-181.

Tu ZJ, Kollander R, Kiang DT.  Differential Upregulation of Gap Junction Connexin 26 Gene in Mammary and Uterine Tissues:  The Role of Sp Transcription Factors.  Mol Endocrinol 1998; 12:  1931-1938.

Singal R, Tu ZJ, VanWert JM, Ginder G, Kiang DT.  Modulation of the Connexin 26 Tumor Suppressor Gene Through Methylation in Immortalized and Malignant Human Mammary Epithelial Cells.  Anticancer Res 2000; 20:  59-64.

Tu ZJ, Pan W, Gong, Kiang DT.  Involving AP-2 Transcript ion Factor in Connexin 26 Up-regulation During Pregnancy and Lactation.  Mol Reprod Dev 2001; 59:  17-24.

Sladek NE, Kollander R, Sreerama L, Kiang DT.  Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: A retrospective study.  Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.  Cancer Chemother Pharmacol 2002; 49:309-321.